Welcome to our dedicated page for Liquidia SEC filings (Ticker: LQDA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Liquidia's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Liquidia's regulatory disclosures and financial reporting.
Liquidia Corp CFO and COO Michael Kaseta exercised performance stock units to acquire 12,879 shares of common stock on July 10, 2026, then sold 20,430 shares of common stock on July 13, 2026 at prices of $71.52 and $71.39 per share. Footnotes state these sales were made under a Rule 10b5-1 plan to cover taxes from RSU and PSU settlements granted between 2023 and 2025. After these transactions, Kaseta directly holds 345,805 common shares, along with various unvested RSU and PSU awards.
Liquidia Corp Chief Executive Officer Roger Jeffs reported multiple equity transactions. On July 13, 2026 he completed open-market sales of 35,249 common shares at prices of $71.52 and $71.39 per share, executed under a Rule 10b5-1 plan and described as sales to cover taxes from RSU and PSU settlements. Earlier, on July 10, 2026 he exercised 28,167 performance stock units, which convert into common stock on a one-for-one basis. Following these transactions, he holds 1,130,426 Liquidia shares directly, plus substantial indirect holdings through a living trust and Serendipity BioPharma LLC, and significant unvested RSU and PSU awards.
Liquidia Corp Chief Business Officer Jason Adair reported a combination of equity award settlements and tax-related share sales. On July 13, 2026 he executed open-market sales of 7,863 common shares at about $71.40–$71.52, sold to cover taxes on recently settled RSUs and PSUs under a Rule 10b5-1 plan. On July 10, 2026 he exercised equity awards, converting 10,251 performance and restricted stock units into common stock.
Liquidia general counsel Russell Schundler exercised performance stock units into 10,168 common shares on July 10, 2026, then sold 14,738 shares on July 13 at prices of $71.52 and $71.39 per share under a pre-arranged Rule 10b5-1 plan to cover tax obligations. He continues to hold 605,962 shares directly, 14,500 shares indirectly through his spouse, and unvested RSUs and PSUs from prior grants.
Liquidia Corp Chief Medical Officer Rajeev Saggar reported both equity award exercises and share sales. On July 10, 2026, he converted 4,487 and 3,531 performance stock units into the same number of common shares at $0.00 per unit. On July 13, 2026, he made open-market sales totaling 9,926 common shares at prices of $71.52 and $71.39 per share, executed under a Rule 10b5-1 plan adopted on December 15, 2023. A footnote states these sales were made to cover taxes from the settlement of previously granted RSUs and PSUs, while he continues to hold a significant direct equity position and additional unvested awards.
Liquidia Corp Chief Commercial Officer Scott Moomaw exercised performance stock units on July 10, 2026, receiving 7,466 shares of common stock as PSUs converted one-for-one. On July 13, 2026, he sold 9,539 shares at prices between $71.39 and $71.52 per share under a Rule 10b5-1 plan to cover taxes tied to RSU and PSU settlements. After these transactions, he holds 182,485 common shares directly, alongside various unvested RSU and PSU awards.
Liquidia Corp Chief Accounting Officer Dana Boyle exercised 3,179 performance stock units into common stock on July 10, 2026, then sold a total of 9,002 common shares on July 13, 2026 at prices of $71.52 and $71.39 per share in open-market transactions.
The PSUs convert into common stock on a one-for-one basis, and the sales were effected under a Rule 10b5-1 trading plan to cover taxes from the settlement of RSUs and PSUs granted on January 11, 2024, January 11, 2025 and July 1, 2025. Boyle continues to hold direct common stock and multiple unvested RSU and PSU awards.
Liquidia Corp director‑associated entity reports open-market sales of Common Stock. An investment entity, Canaan VIII L.P., which is associated with director Stephen M. Bloch, sold a total of 75,000 shares of Liquidia Common Stock in open-market transactions at weighted average prices around the low-$80 range.
These sales were executed indirectly through the Canaan entities, which hold the shares and whose managers collectively make investment and voting decisions. The filing states that Bloch disclaims beneficial ownership of these securities except to the extent of any pecuniary interest, and that he did not participate in the investment decision under a communications-screen policy.
BlackRock, Inc. reports beneficial ownership of 10,551,901 shares of LIQUIDIA CORP common stock, equal to 11.9% of the class as of 06/30/2026. The filing lists 10,434,552 shares of sole voting power and 10,551,901 shares of sole dispositive power. The amendment is signed 07/08/2026.
Liquidia Corp director Stephen M. Bloch reported stock transactions mainly involving an investment fund he is associated with. Canaan VIII L.P. sold 24,147 shares of Liquidia common stock at a weighted average price of $79.4474 and 853 shares at a weighted average price of $80.045.
After these sales, entities associated with Canaan VIII L.P. held 855,926 Liquidia shares indirectly, while Bloch held 71,594 shares directly. Footnotes state that Canaan Partners VIII LLC managers collectively make investment and voting decisions, and Bloch disclaims beneficial ownership of the Canaan-held shares except for any pecuniary interest and did not participate in this investment decision.